RIXATHON conc perf 500 mg/50ml amp 50 ml
7680664350036
CH-66435
L01FA01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6643502
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- rituximabum 500 mg, acidum citricum monohydricum, natrii chloridum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 177.03 mg.
Articles (1)
Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rituximabum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
177.03 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1159.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2018
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66435
- Drug name
- Rixathon, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/07/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RIXATHON conc perf 500 mg/50ml amp 50 ml
- Description (DE)
- RIXATHON Inf Konz 500 mg/50ml Amp 50 ml
- Market launch
- 03/07/2018
- Narcotic (BTM)
- No